Literature DB >> 853503

Nonenolizable podophyllotoxin derivatives.

W J Gensler, C D Murthy, M H Trammell.   

Abstract

To block epimerization and the resulting biological deactivation podophyllotoxin compounds, the lactone carbonyl group has been changed to methylene. Syntheses of several of these delactonized derivatives are described, all with modifications in the original lactone ring and some without the 4-hydroxyl group. Several biological assays show that most of the nonenolizable derivatives retain activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 853503     DOI: 10.1021/jm00215a004

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  N-hydroxyethyl-4-aza-didehydropodophyllotoxin derivatives as potential antitumor agents.

Authors:  Ajay Kumar; Vineet Kumar; Antonio E Alegria; Sanjay V Malhotra
Journal:  Eur J Pharm Sci       Date:  2011-05-13       Impact factor: 4.384

2.  Structural simplification of bioactive natural products with multicomponent synthesis: dihydropyridopyrazole analogues of podophyllotoxin.

Authors:  Igor V Magedov; Madhuri Manpadi; Elena Rozhkova; Nikolai M Przheval'skii; Snezna Rogelj; Scott T Shors; Wim F A Steelant; Severine Van slambrouck; Alexander Kornienko
Journal:  Bioorg Med Chem Lett       Date:  2006-12-06       Impact factor: 2.823

Review 3.  Synthetic and application perspectives of azapodophyllotoxins: alternative scaffolds of podophyllotoxin.

Authors:  A Kumar; V Kumar; A E Alegria; S V Malhotra
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Azapodophyllotoxin Causes Lymphoma and Kidney Cancer Regression by Disrupting Tubulin and Monoglycerols.

Authors:  Arvin M Gouw; Vineet Kumar; Angel Resendez; Fidelia B Alvina; Natalie S Liu; Katherine Margulis; Ling Tong; Richard N Zare; Sanjay V Malhotra; Dean W Felsher
Journal:  ACS Med Chem Lett       Date:  2022-03-30       Impact factor: 4.632

5.  Pharmacokinetics of Teniposide (VM26) and etoposide (VP16-213) in children with cancer.

Authors:  W E Evans; J A Sinkule; W R Crom; L Dow; A T Look; G Rivera
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

6.  Design and synthesis of 6,7-methylenedioxy-4-substituted phenylquinolin-2(1H)-one derivatives as novel anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase.

Authors:  Yi-Fong Chen; Yi-Chien Lin; Po-Kai Huang; Hsu-Chin Chan; Sheng-Chu Kuo; Kuo-Hsiung Lee; Li-Jiau Huang
Journal:  Bioorg Med Chem       Date:  2013-06-26       Impact factor: 3.641

Review 7.  The clinical pharmacology of etoposide and teniposide.

Authors:  P I Clark; M L Slevin
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

Review 8.  Podophyllotoxin: History, Recent Advances and Future Prospects.

Authors:  Zinnia Shah; Umar Farooq Gohar; Iffat Jamshed; Aamir Mushtaq; Hamid Mukhtar; Muhammad Zia-Ui-Haq; Sebastian Ionut Toma; Rosana Manea; Marius Moga; Bianca Popovici
Journal:  Biomolecules       Date:  2021-04-19

9.  Novel cis-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cells.

Authors:  Sahar Kandil; Jennifer M Wymant; Benson M Kariuki; Arwyn T Jones; Christopher McGuigan; Andrew D Westwell
Journal:  Eur J Med Chem       Date:  2015-12-23       Impact factor: 6.514

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.